| 摘要 |
The invention provides methods of treating cancer with a compound which i nhibits kinases, more specifically IGF1R and Abl, in combination with treatm ents(s) selected from surgery, radiation, monoclonal antibody, bone marrow o r peripheral blood stem cell transplantation, and one or more chemotherapeut ic agent(s).
|
